Author:
Xu Xiao-Ling,Chen Shu-Zheng,Chen Wei,Zheng Wei-Hui,Xia Xiang-Hou,Yang Hong-Jian,Li Bo,Mao Wei-Min
Publisher
Springer Science and Business Media LLC
Reference67 articles.
1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM. GLOBOCAN 2008 v2.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 10 (Internet). Lyon, France: International Agency for Research on Cancer, 2010
2. Guan X, Wang Y, Xie R, Chen L, Bai J, Lu J, Kuo MT (2010) p27(Kip1) as a prognostic factor in breast cancer: a systematic review and meta-analysis. J Cell Mol Med 14(4):944–953. doi: 10.1111/j.1582-4934.2009.00730.x
3. Wang J, Guo Y, Wang B, Bi J, Li K, Liang X, Chu H, Jiang H (2012) Lymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature. Mol Biol Rep 39(12):11153–11165. doi: 10.1007/s11033-012-2024-y
4. Kim HS, Moon HG, Han W, Yom CK, Kim WH, Kim JH, Noh DY (2012) COX2 overexpression is a prognostic marker for Stage III breast cancer. Breast Cancer Res Treat 132(1):51–59. doi: 10.1007/s10549-011-1521-3
5. Callagy GM, Webber MJ, Pharoah PD, Caldas C (2008) Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer. BMC Cancer 8:153. doi: 10.1186/1471-2407-8-153
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献